Biotech Series C Investors & VC Firms
430 firms in this list, with a median first check of $648K. 101 of them lead rounds. Generated from verified public data and updated continuously.
Pureos Bioventures
PfäffikonSeed–Series C
9 people
Cultivian Sandbox Ventures
ChicagoSeed–Late Stage$5M – $15M
8 people
Santen Pharmaceutical
OsakaSeries A–Series C
24 people
Fine Structures Ventures
CambridgePre-Seed–Late Stage
10 people
Redesign Health
New YorkSeed–Late Stage
13 people
Yuanta Investment
SeoulSeed–Late Stage$1M – $15M
20 people
Tin Alley Ventures
MelbourneSeed–Late Stage
13 people
Infinitas Capital
Pre-Seed–Late Stage
17 people
Luma Group
New YorkSeed–Growth
14 people
Triatomic Capital
Palo AltoSeed–Series C$100K – $1M
8 people
Roche Venture Fund
BaselSeed–Growth$648K – $3.2M
8 people
Morgenthaler
Portola ValleyPre-Seed–Series C
8 people
Maxpro Ventures
TaipeiSeed–Late Stage
7 people
Leaps by Bayer
LeverkusenSeed–Growth
6 people
Happiness Capital
Hong KongSeed–Growth
7 people
Detong Capital
ShanghaiSeed–Growth$20M
11 people
HM Venture Partners
San FranciscoSeed–Growth
7 people
Dementia Discovery
LondonSeed–Series C
15 people
Presight Capital
SliemaPre-Seed–Growth$500K – $20M
4 people
TVM Capital
MunichSeed–Late Stage$1.1M – $16.2M
10 people
Texas Ventures
HoustonSeed–Late Stage
6 people
PM Equity Partner
LausanneSeries A–Growth$2M – $50M
11 people
2050 Capital
LondonSeed–Series C$200K – $3M
7 people
Sound Bioventures
MalmöSeed–Growth
9 people
Related lists
Biotech Investors & VC Firms (2504)Biotech Seed Investors & VC Firms (2043)Series C Investors & VC Firms (1709)Biotech Series A Investors & VC Firms (1638)Biotech Investors & VC Firms in North America (1618)Biotech Investors & VC Firms in United States (1466)Biotech Investors & VC Firms in Europe (961)Series C Investors & VC Firms in North America (942)Biotech Pre-Seed Investors & VC Firms (931)Biotech Investors & VC Firms in Global (826)
Data sourced from public filings and firms' own websites — see our methodology.
































































































